# ITERUM THERAPEUTICS PLC (ITRMF)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ITRMF/

- Reporting holders: 2
- Reported value: $542
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $539 | 10,795 | 0.0% | 1 |
| [Cypress Capital Management LLC (WY)](https://holderbook.com/funds/1633896-cypress-capital-management-llc-wy/) | $3 | 66 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 16 | $483.0K |
| Q3 2025 | 19 | $798.9K |
| Q2 2025 | 20 | $2.3M |
| Q1 2025 | 18 | $1.3M |
| Q4 2024 | 20 | $2.1M |
| Q3 2024 | 15 | $2.2M |
| Q2 2024 | 14 | $494.7K |
| Q1 2024 | 15 | $1.4M |
| Q4 2023 | 14 | $772.2K |
| Q3 2023 | 13 | $183.9K |